130 related articles for article (PubMed ID: 26215070)
1. Important factors determining prognosis based on SUVmax in PET imaging.
Şahin E; Akcan AB
Turk J Gastroenterol; 2015 Sep; 26(5):442. PubMed ID: 26215070
[No Abstract] [Full Text] [Related]
2. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Cho E; Jun CH; Kim BS; Son DJ; Choi WS; Choi SK
Turk J Gastroenterol; 2015 Jul; 26(4):344-50. PubMed ID: 26039005
[TBL] [Abstract][Full Text] [Related]
3. Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR.
Freesmeyer M; Lopatta E; Schierz JH; Steenbeck J; Opfermann T; Settmacher U
Nuklearmedizin; 2012; 51(1):N10-1. PubMed ID: 22336884
[No Abstract] [Full Text] [Related]
4. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
[TBL] [Abstract][Full Text] [Related]
5. Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
Kawamura E; Shiomi S; Kotani K; Kawabe J; Hagihara A; Fujii H; Uchida-Kobayashi S; Iwai S; Morikawa H; Enomoto M; Murakami Y; Tamori A; Kawada N
J Gastroenterol Hepatol; 2014 Sep; 29(9):1722-7. PubMed ID: 24730671
[TBL] [Abstract][Full Text] [Related]
6. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Lee JW; Paeng JC; Kang KW; Kwon HW; Suh KS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2009 May; 50(5):682-7. PubMed ID: 19372474
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma.
Siemerink EJ; Mulder NH; Brouwers AH; Hospers GA
Oncologist; 2008 Jun; 13(6):734-5; author reply 736-7. PubMed ID: 18586929
[No Abstract] [Full Text] [Related]
8. [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
Asman Y; Evenson AR; Even-Sapir E; Shibolet O
Liver Transpl; 2015 May; 21(5):572-80. PubMed ID: 25644857
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging.
Beadsmoore CJ; Cheow HK; Sala E; Lomas DJ; Gibbs P; Save V; Alison ME; Balan KK
Br J Radiol; 2005 Sep; 78(933):841-4. PubMed ID: 16110108
[TBL] [Abstract][Full Text] [Related]
11. Sarcomatoid hepatocellular carcinoma diagnosed by FDG PET/CT.
Mi B; Wan W; Yu C; You X; Xu Q
Clin Nucl Med; 2011 Oct; 36(10):925-7. PubMed ID: 21892049
[No Abstract] [Full Text] [Related]
12. 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.
Hanajiri K; Mitsui H; Maruyama T; Kondo Y; Shiina S; Omata M; Nakagawa K
J Gastroenterol; 2005 Oct; 40(10):1005-6. PubMed ID: 16261443
[No Abstract] [Full Text] [Related]
13. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
Takemoto K; Hatano E; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Matsumura K; Zaima M; Toriguchi K; Tanabe K; Kitamura K; Seo S; Taura K; Endo K; Uemoto S; Higashi T
Ann Nucl Med; 2014 May; 28(4):371-80. PubMed ID: 24599824
[TBL] [Abstract][Full Text] [Related]
14. Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin.
Algin E; Ozet A; Gumusay O; Cetin B; Akdemir UO; Benekli M; Coskun U; Uner A; Kapucu O; Buyukberber S
Ann Nucl Med; 2014 Nov; 28(9):891-6. PubMed ID: 25270711
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee SD; Kim SH; Kim SK; Kim YK; Park SJ
Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
[TBL] [Abstract][Full Text] [Related]
16. A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging.
Jiang L; Gu T; Liu F; Luan L; Shi H
Clin Nucl Med; 2016 Jan; 41(1):72-3. PubMed ID: 26359556
[TBL] [Abstract][Full Text] [Related]
17. FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.
Kurtovic J; Van Der Wall H; Riordan SM
Clin Nucl Med; 2005 Jun; 30(6):408-10. PubMed ID: 15891293
[No Abstract] [Full Text] [Related]
18. FDG PET/CT and enhanced CT imaging of tumor heterogeneity in hepatocellular carcinoma: imaging-pathologic correlation.
Dong A; Yu H; Wang Y; Dong H; Zuo C
Clin Nucl Med; 2014 Sep; 39(9):808-10. PubMed ID: 24092231
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
He YX; Guo QY
Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
[TBL] [Abstract][Full Text] [Related]
20. Primary hepatic angiosarcoma on coregistered FDG PET and CT images.
Maeda T; Tateishi U; Hasegawa T; Ojima H; Arai Y; Sugimura K
AJR Am J Roentgenol; 2007 Jun; 188(6):1615-7. PubMed ID: 17515384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
